The anticholinergic propiverine (1-methyl-4-piperidyl diphenylpropoxyacetate), which is used for the treatment of overactive bladder syndrome, has functionally active metabolites [M-1 (1-methyl-4-piperidyl diphenylpropoxyacetate N-oxide) and M-2 (1-methyl-4-piperidyl benzilate N-oxide)], but the site of actions of these metabolites is uncertain. Propiverine is rapidly absorbed after oral administration and is extensively biotransformed in the liver, giving rise to several active metabolites (M-1 and M-2). This study determines the effect of M-1 and M-2 on voltage-dependent nifedipine-sensitive inward Ca 2ϩ currents (I Ca ) using patch-clamp techniques and fluorescent Ca 2ϩ imaging [after electrical field stimulation (EFS) and acetylcholine (ACh)] in the murine urinary bladder. In conventional whole-cell recording, propiverine and M-1 but not M-2 inhibited the peak amplitude of I Ca in a concentration-dependent manner at a holding potential of Ϫ60 mV (propiverine, K i ϭ 10 M; M-1, K i ϭ 118 M). M-1 shifted the steady-state inactivation curve of I Ca to the left at Ϫ90 mV by 7 mV. Carbachol (CCh) reversibly inhibited I Ca . This inhibition probably occurred through muscarinic type 3 receptors, coupling with G-proteins, because nanomolar concentrations of 4-diphenylacetoxy-N-methyl-piperidine greatly reduced this inhibition, whereas pirenzepine or ,4]benzodiazepine-6-one (AF-DX 116) at concentrations up to 1 M was almost ineffective. In the presence of M-2, the CCh-induced inhibition of I Ca was blocked. In fluorescent Ca 2ϩ imaging, M-2 inhibited EFS-induced and ACh-induced Ca 2ϩ transients. These results suggest that M-1 acts, at least in part, as a Ca 2ϩ channel antagonist (as it inhibited I Ca ), whereas M-2 has more direct antimuscarinic actions.
118 M). M-1 shifted the steady-state inactivation curve of I Ca to the left at Ϫ90 mV by 7 mV. Carbachol (CCh) reversibly inhibited I Ca . This inhibition probably occurred through muscarinic type 3 receptors, coupling with G-proteins, because nanomolar concentrations of 4-diphenylacetoxy-N-methyl-piperidine greatly reduced this inhibition, whereas pirenzepine or 11-([2-[(diethylamino)methyl]-1-piperdinyl]acetyl)-5,11-dihydro-6H-pyrido[2, 3-b] [1,4]benzodiazepine-6-one (AF-DX 116) at concentrations up to 1 M was almost ineffective. In the presence of M-2, the CCh-induced inhibition of I Ca was blocked. In fluorescent Ca 2ϩ imaging, M-2 inhibited EFS-induced and ACh-induced Ca 2ϩ transients. These results suggest that M-1 acts, at least in part, as a Ca 2ϩ channel antagonist (as it inhibited I Ca ), whereas M-2 has more direct antimuscarinic actions.
It is well known that contraction of the urinary bladder, voluntary or involuntary, is mediated by stimulation of muscarinic receptors by acetylcholine (ACh), which is released from excited cholinergic parasympathetic nerves. Because muscarinic receptors mediate both normal detrusor contraction and the principal contractions of disturbed urinary bladder, muscarinic receptors are useful drug targets to regulate the function of urinary bladder. Thus, various anticholinergic drugs have been used for the treatment of overactive bladder syndrome, but their usefulness is limited by significant side effects (Andersson et al., 1999; Fry et al., 2002; Herbison et al., 2003; Michel and Hegde, 2006) . However, many antimuscarinic drugs act, at least in part, as prodrugs, so their metabolites might provide effective therapies with fewer side effects ( Michel and Hegde, 2006) .
Propiverine (1-methyl-4-piperidyl diphenylpropoxyacetate) is an anticholinergic agent that is commonly used for the treatment of patients with overactive bladders (Madersbacher et al., 1999; Dorschner et al., 2000) . Propiverine is rapidly absorbed after oral administration and is extensively biotransformed in the liver, giving rise to several active metabolites [such as M-1 (1-methyl-4-piperidyl diphenylpropoxyacetate N-oxide) and M-2 (1-methyl-4-piperidyl benzilate N-oxide)] for chemical structures ( Fig. 1 ) (Wuest et al., 2005; Uchida et al., 2007) . Twenty-four hours after ingestion, these compounds can be recovered from other derivatives of human urine (as a percentage of the original dose): 3% propiverine; 20% M-1; and 5% M-2 ( Haustein and Hü ller, 1988) . Moreover, after 5 days of treatment with propiverine in a single-dose application, both propiverine and M-1 were detected in the serum, whereas M-2 was not detectable in the serum (Siepmann et al., 1998) . Despite their high in vivo concentrations (M-1 reaches a peak of ϳ2 M) (Siepmann et al., 1998) and the pharmacological properties of propiverine, metabolites remain elusive (Andersson et al., 1999; Madersbacher and Murtz, 2001) . Thus, it is essential to investigate whether the two main metabolites of propiverine (M-1 and M-2) are related to the therapeutic actions of propiverine ( Michel and Hegde, 2006) . It has been reported that propiverine seems to possess spasmolytic effects as a Ca 2ϩ channel antagonist in addition to its antimuscarinic actions (Andersson et al., 1999; Madersbacher and Murtz, 2001 ). The contraction, in response to muscarinic receptor activation in the urinary bladder (particularly in the mouse but also in humans), is sensitive to pharmacological blockade of L-type Ca 2ϩ channels (Wuest et al., 2007) and depends significantly on the Ca V 1.2 gene (smooth muscle ␣1C-subunit Ca 2ϩ channels) (Wegener et al., 2004) . The most well established link between muscarinic receptors and L-type Ca 2ϩ channels is an indirect one. Intracellular Ca 2ϩ stores are released after muscarinic receptor activation, and their filling requires L-type Ca 2ϩ channels, at least in the guinea pig (Rivera and Brading, 2006) . However, in the rat urinary bladder, contraction caused by muscarinic type 3 receptor activation is not inhibited by effective phospholipase C inhibition with U 73,122 (Schneider et al., 2004) . Furthermore, phospholipase D and phospholipase A 2 pathways play only a minor role in the contraction that follows this muscarinic receptor activation (Schneider et al., 2004) , implying that other as yet unidentified pathways functionally link the functionally important muscarinic type 3 receptors with L-type Ca 2ϩ channels. In patch-clamp experiments, propiverine inhibited the peak amplitude of voltage-dependent Ca 2ϩ currents in detrusor myocytes: murine (Wuest et al., 2005) , rat (Tokuno et al., 1993) , guinea pig (Tokuno et al., 1993) , and human (Wuest et al., 2005) . However, surprisingly, neither M-1 nor M-2 caused inhibitory effects on voltage-dependent Ca 2ϩ currents in murine detrusor myocytes (Wuest et al., 2005) . Furthermore, although functional interactions between muscarinic receptors and voltage-dependent Ca 2ϩ currents were reported in urinary bladder smooth muscle cells (Fry et al., 2002; Schneider et al., 2004) , the question of which muscarinic receptors might regulate voltage-dependent Ca 2ϩ currents remains to be elucidated. Moreover, the effects of two main propiverine metabolites on Ca 2ϩ transients in intact smooth muscle cells in intact urinary bladder have not been directly measured.
Therefore, in the present experiments, we initially studied the effects of propiverine and two of its main metabolites (M-1 and M-2) on voltage-dependent nifedipine-sensitive inward Ca 2ϩ currents (I Ca ; i.e., caused by Ca 2ϩ entry through L-type Ca 2ϩ channels) in single, freshly dispersed smooth muscle cells from murine urinary bladder using patch-clamp techniques. We further investigated whether M-2 prevented the carbachol (CCh)-induced inhibition of I Ca through muscarinic receptors in whole-cell recordings. Finally, we studied the actions of M-2 on the electrical field stimulation-induced and ACh-induced Ca 2ϩ transients in murine detrusor muscles with fluorescent Ca 2ϩ imaging.
Materials and Methods
Cell Dispersion. Eight-to 12-week-old male BALB/c mice (Charles River Laboratories Inc., Shiga, Japan; Harlan, Bicester, UK) were killed by cervical fracture, and the urinary bladders were removed. A segment of detrusor was excised and quickly transferred into nominally Ca 2ϩ -free solution: 140 mM Na ϩ , 5 mM K ϩ , 0.5 mM Mg 2ϩ , 146 mM Cl Ϫ , and 10 mM HEPES, titrated to pH 7.35 to 7.40 with Tris base. Murine detrusor myocytes were freshly isolated under a microscope by gently tapping after treatment with collagenase (Type IA, 1-2 mg/ml; Sigma Chemical K.K., Tokyo, Japan), as described previously (Teramoto and Brading, 1996) . Relaxed spindleshaped cells were isolated and stored at 4°C. The dispersed cells were used within 4 to 5 h for experiments.
Recording Procedure. Patch-clamp experiments were performed at room temperature (21-23°C) as described previously (Teramoto et al., 2005) . Junction potentials between bath and pipette solutions were measured with a 3 M KCl reference electrode and were Ͻ2 mV, so that correction of these potentials was not necessary. Capacitance noise was kept to a minimum by maintaining the bath solution in the electrode as low as possible. After establishing a conventional whole-cell configuration, I Ca evoked by a depolarizing pulse to 0 mV from a holding potential of Ϫ60 mV increased slightly in amplitude until the peak currents reached steady state approxi- 
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mately 4 min after the rupture of the membrane patch. This peak value was then maintained for at least 30 min (the peak amplitude of I Ca at 30 min being 98 Ϯ 1% to control; n ϭ 15 cells; 10 different animals) when test depolarization pulses (500 ms duration) were applied at 20-s intervals in conventional whole-cell recording. As a result, all experiments were performed within 30 min after the peak amplitude of I Ca became stable in a conventional whole-cell configuration at Ϫ60 mV. . Propiverine and its active metabolites (M-1 and M-2) (Wuest et al., 2005; Uchida et al., 2007) were kindly provided by Taiho Pharmaceutical Co. Ltd. (Tokushima, Japan) (see Fig. 1 ). AF-DX 116 (Watson et al., 1986 ) and 4-DAMP ( Thomas and Ehlert, 1992) were purchased from Sigma-Aldrich (Tokyo, Japan). The rest of the drugs were also obtained from Sigma-Aldrich. AF-DX 116, M-1, and M-2 were prepared as 100 mM stock solutions in dimethyl sulfoxide (DMSO). The final concentration of DMSO was less than 0.3%, and this concentration did not affect I Ca in murine urinary bladder.
Data Analysis. The whole-cell current data were low-pass filtered at 1 kHz with an 8-pole Bessel filter, sampled at 1 kHz, and analyzed on a computer (PowerMac G4; Tokyo, Japan) by the commercial software "PowerLab" (ADInstruments Pty Ltd., Castle Hill, Australia). Data are expressed as mean Ϯ S.E.M. To account for leak and capacitive currents, I Ca in the presence of 100 M Cd 2ϩ was subtracted from the raw current data (Teramoto et al., 2005) .
The peak amplitude of I Ca elicited by a step pulse to 0 mV from the holding potential just before application of a drug was normalized as one. Curves were drawn by fitting the following equation using the least-squares method:
Relative amplitude of I Ca ϭ 1
where K i , D, and n H are the inhibitory dissociation constant, concentration of drug (micromolar), and Hill coefficient, respectively. Conditioning pulses of various amplitudes were applied (up to ϩ 40 mV, 10-s duration) before application of the test pulse (up to 0 mV, 500-ms duration) from a holding potential of Ϫ100 mV. An interval of 20 ms was allowed between these two pulses to estimate possible contamination by capacitive current. The peak amplitude of I Ca evoked by each test pulse was measured before and after application of drugs. The peak amplitude of I Ca in the absence and presence of drugs without application of any conditioning pulse was normalized to one. The lines were drawn by fitting the data to the following equation using the least-squares method,
including the following parameters: the relative amplitude of I Ca observed at various amplitudes of conditioning pulse (I); the relative amplitude of I Ca observed with a Ϫ100 mV conditioning pulse (I max ); the amplitude of the conditioning pulse (V); the conditioning pulse amplitude (V half ) that evokes I Ca of amplitude half-I max ; a slope factor (k); and the fraction of the noninactivating component of I Ca (C). Activation curves were derived from the current-voltage relationships. Conductance (G) was calculated from the equation G ϭ I Ca / (E m Ϫ E Ca ), where I Ca is the peak current elicited by depolarizing test pulses of Ϫ50 to ϩ40 mV from a holding membrane potential of Ϫ60 mV and E Ca is the equilibrium potential for Ca 2ϩ . G max is the maximal Ca 2ϩ conductance (calculated at potentials above 0 mV). Values for G/G max (a relative amplitude) were plotted against membrane potential. Ca 2؉ Transients. The urinary bladder was cut from base to dome and exposed to 10 M Oregon Green 488 and 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid 1/AM (Invitrogen, Paisley, UK) in 1% DMSO/0.2% Pluronic F-127 (Sigma-Aldrich) in physiological salt solution (PSS) for 90 min at 36°C. Each urinary bladder was then pinned flat, with serosal side up, in a Sylgard-lined organ bath and rinsed in PSS containing the following components: 144.53 mM Na ϩ , 4.7 mM K ϩ , 1.3 mM Mg 2ϩ ,1.8 mM Ca 2ϩ , 129.3 mM Cl Ϫ , 25 mM HCO 3 Ϫ , 1.13 mM H 2 PO 4 Ϫ , and 11.1 mM glucose, which was bubbled with 95% O 2 and 5% CO 2 . This preparation was transferred to the stage of an upright Olympus microscope with a 40 ϫ 0.8-numerical aperture water immersion objective and a Hamamatsu ORCA-AG camera. The urinary bladders were continuously superfused with PSS (bath temperature 33-34°C). A series of 1000 frames were captured using Wasabi software (Hamamatsu Photonics Deutschland, Herrsching, Germany) at 20 Ϯ 1 Hz with 4 ϫ 4 on-chip binning to generate a one-image set. Such sets were acquired once every 3 min. Three such sets were acquired at each drug concentration (or protocol step). Image analysis was performed with Image SXM (http://www.liv.ac.uk/ϳsdb/ImageSXM/) to correct for lateral movement (particularly that generated by contraction); all images were automatically aligned to a template image using the "Autoregister" function of Image SXM and custom-written macros. A region of interest was established to encompass the portion of a smooth muscle cell that was consistently within the field of view. The fluorescent signal in this region was measured over time throughout the image set. Data were exported to Spike 2 (Cambridge Electronic Design Ltd., Cambridge, UK) for automated detection and measurement of spikes in the Ca 2ϩ signal. The threshold for spike detection (based on the amplitude of the first derivative of the fluorescent signal) was manually chosen to match the sensitivity of manual detection for that cell. The Ca 2ϩ wave frequency was calculated by counting the number of waves crossing a small, randomly chosen region in each of three smooth muscle cells from each preparation. The smooth muscle cells were chosen to be well separated (wherever possible) and clearly in focus throughout at least 50% of the recording period. Some portions of the recordings could not be analyzed because of preparation movement (including contraction).
Immunohistochemical Studies. Tissue samples from murine urinary bladder were embedded in OCT compound (Tissues-Tek; SAKURA, Tokyo, Japan) in disposable plastic tubes and rapidly frozen in hexane surrounded by liquid nitrogen. Sections were cut in a cryostat (Leica CM3050S; Leica Microsystems, Tokyo, Japan) at a thickness of 6 m, mounted on silane-precoated glass slides, and then allowed to air dry at room temperature for approximately 30 min. Sections were fixed in ice-cold acetone (4°C) and washed thoroughly in phosphate-buffered saline (PBS) before staining. The tissue sections were treated in 2% normal goat serum (Santa Cruz Biotechnology, Santa Cruz, CA), 1% bovine serum albumin (GIBCO, Grand Island, NY), and 0.1% Triton X-100 (Amersham Biosciences, Uppsala, Sweden) in PBS for 1 h to avoid nonspecific staining and then reacted with the primary antibody, polyclonal rabbit antimuscarinic type 3 receptor (Santa Cruz Biotechnology) antibody (diluted at 1:200), at 4°C overnight. After washing three times (5-min duration) in PBS, sections were incubated with phycoerythrin-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology) diluted to 1:50 in PBS for 60 min at room temperature under dark conditions. Sections were then washed three times (5-min duration) in PBS. Coverslips were mounted onto slides with a fluorescence mounting medium, and the slides were viewed with a fluorescence microscope (Olympus BX51; Olympus Optical Co. Ltd., Tokyo, Japan). Nonimmunized rabbit IgG was also used instead of the primary antibody as a negative control.
Statistics. Statistical analyses were performed with a paired t test (two-factor with replication). Original raw data were compared using a t test. Changes were considered significant at P Ͻ 0.05.
Results
Electrophysiological Properties of Voltage-Dependent Ca 2؉ Currents in Murine Urinary Bladder Myocytes. When depolarizing step pulses (10-mV increments from Ϫ50 mV to ϩ40 mV for 500-ms duration) were applied from a holding potential of Ϫ60 mV in whole-cell recordings, voltage-dependent Ca 2ϩ inward currents (I Ca ) were evoked in murine urinary bladder myocytes. As shown in Fig. 2A , at potentials more positive than Ϫ40 mV, I Ca was evoked that reached a peak and then gradually decayed. Figure 2C shows the current-voltage relationships of I Ca obtained from a holding potential of Ϫ60 mV. The maximal peak amplitude was obtained at approximately 0 mV, and the amplitude was reduced at more positive potentials. M-1 (100 M) inhibited the peak amplitude of I Ca evoked by depolarizing pulses (500-ms duration) from a holding potential of Ϫ60 mV to potentials more positive than Ϫ30 mV (Fig. 2, A and B) . When the peak amplitude of I Ca in the absence (i.e., control) and presence of M-1 was superimposed, the time course of current decay was accelerated in the presence of 100 M M-1 (Fig. 2B) . Figure 2C shows the current-voltage relationships of I Ca in the absence and presence of 100 M M-1 (n ϭ 5 cells, three different animals).
Effects of M-1 and M-2 on I Ca in Murine Urinary Bladder Myocytes. Figure 3A shows the time course of the effect of M-1 on I Ca evoked by a depolarizing pulse to 0 mV from Ϫ60 mV after M-1 (10 and 100 M) had been cumulatively applied. The depolarizing pulses were applied every 20 s. M-1 (10 and 100 M) reduced the peak amplitude of I Ca . Upon removal of M-1, the peak amplitude of I Ca gradually recovered but not to the control level. As a result, application of 10 M nifedipine suppressed I Ca to zero. Figure 3B shows the time course of the effects of M-2 (10 and 100 M) on I Ca evoked by a depolarizing pulse to 0 mV from a holding potential of Ϫ60 mV. Although M-2 (Յ10 M) caused no reduction of the peak amplitude of I Ca , M-2 (Ն100 M) caused a small but significant inhibition (100 M, 0.87 Ϯ 0.07, n ϭ 5 cells, P Ͻ 0.05, three different animals; 1 mM, 0.84 Ϯ 0.09, n ϭ 4 cells, P Ͻ 0.05, three different animals; Fig. 3C ). After removal of 100 M M-2, the peak amplitude of I Ca was recovered. Subsequent application of nifedipine (10 M) suppressed I Ca . Figure 3C shows the relative peak amplitude of I Ca evoked by depolarizing pulses to 0 mV from two different holding potentials (Ϫ60 and Ϫ90 mV) that were applied every 20 s and plotted against concentrations of M-1, M-2, or propiverine. M-1 inhibited the peak amplitude of I Ca in a concentration-dependent manner (Ϫ60 mV,
The voltage dependence was investigated before and after application of M-1 using the double-pulse experimental protocol shown in Fig. 4 . Steady-state inactivation was determined by giving long conditioning pulses (10-s duration) before a test pulse (500-ms duration; see the inset in Fig. 4 ). In the absence of M-1 (control), inactivation of I Ca occurred with depolarizing pulses more positive than Ϫ50 mV. After application of M-1 (approximately 5 min later), the voltage-dependent inactivation curve (the 50% inactivation potentials) in the same cells was significantly shifted to the left (by approximately 7 mV; control, Ϫ36.0 Ϯ 1.5 mV, n ϭ 6 cells, three different animals; M-1, Ϫ42.8 Ϯ 2.5 mV, n ϭ 6 cells, three different animals, P Ͻ 0.05). Figure 4 shows that activation curves obtained from the current-voltage relationships (in Fig. 2) 
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Muscarinic Suppression of I Ca in Smooth Muscle
Cells of Murine Urinary Bladder. Figure 5A shows a time course of the effects of CCh (10 and 100 M) on I Ca evoked by a depolarizing pulse to 0 mV from a holding potential of Ϫ60 mV. CCh inhibited the peak amplitude of I Ca in a concentration-dependent manner (Fig. 5B) . Upon removal of CCh, the peak amplitude of I Ca did not recover to the control level. When the pipette solution contained 1 mM GDP␤S, which Peak current values were used. The steady-state inactivation curve was obtained using the double-pulse protocol (see inset). The current measured during the test pulse is plotted against membrane potential and expressed as relative amplitude. The steady-state inactivation curves in the absence or presence of M-1 were drawn using the following values: control, I max ϭ 1.0, V half ϭ Ϫ36 mV, k ϭ 7, and C ϭ 0.05; M-1, 100 M, I max ϭ 1.0, V half ϭ Ϫ43 mV, k ϭ 9, and C ϭ 0.02. Each symbol indicates the mean of six observations (three different animals) with mean Ϯ S.E.M. shown by vertical lines. Activation curves were obtained from the current-voltage relationships of Fig. 2 , fitting to the Boltzmann equation (see Materials and Methods) . The activation curves in the absence or presence of M-1 were drawn using the following values: control, I max ϭ 1.0, V half ϭ Ϫ14 mV, k ϭ 6, and C ϭ 0.01; M-1, 100 M, I max ϭ 1.0, V half ϭ Ϫ13 mV, k ϭ 6, and C ϭ 0.01. Each symbol indicates the mean of five observations (three different animals) with mean Ϯ S.E.M. shown by vertical lines. Some of the S.E.M. bars are smaller than the symbol.
completely inhibits the dissociation of ␣ and ␤␥ complexes of GTP-binding proteins, the application of CCh (100 M) had little effect on the peak amplitude of I Ca . In the presence of 1 M cyclopentolate, CCh (100 M) changed the peak amplitude of I Ca negligibly (Fig. 5B) . To further determine the type of muscarinic receptors involved in the inhibition of I Ca , we tested the effects of three relatively subtype-specific muscarinic antagonists: pirenzepine, AF-DX 116, and 4-DAMP (Eglen et al., 1996) . As shown in Fig. 5B , a 4-min pretreatment with 1 M pirenzepine or AF-DX 116 (concentrations 10 -100 times higher than the K d values for muscarinic type 1 and type 2 receptors) (Eglen et al., 1996) greatly reduced I Ca induced by 100 M CCh. In contrast, in the presence of 100 nM 4-DAMP, a muscarinic type 3 receptor-specific antagonist, the same concentration of CCh failed to inhibit the amplitude of I Ca (Fig. 5B) . Although thorough inspection of antagonism between CCh and the three muscarinic antagonists over the full concentration range was not technically feasible, these results are consistent with the muscarinic receptor involved in I Ca inhibition of the muscarinic type 3 receptors.
Immunohistochemical Localization of Muscarinic Type 3 Receptor in Murine Detrusor. Immunohistochemistry was performed to determine whether muscarinic type 3 receptors were expressed (Fig. 5, C and D) . As shown in Fig.  5D , muscarinic type 3 receptor immunoreactivity is clearly visible in the membranes of the smooth muscle cells. Immunohistochemistry using nonimmune rabbit IgG instead of primary antibody (as a control) gave a negative result (Fig.  5E) . Likewise, no specific immunoreactive signal was seen when primary antibody was preabsorbed with the immunizing muscarinic type 3 receptor antigen (data not shown).
Effect of M-2 on CCh-Induced Suppression of I Ca in Detrusor Smooth Muscle Cells. Figure 6A shows a time course of the effects of CCh (10 and 100 M) on I Ca evoked by a depolarizing pulse to 0 mV from a holding potential of Ϫ60 mV in the absence and presence of 3 M M-2. M-2 had little effect on the peak amplitude of I Ca . Additional application of CCh (10 and 100 M) failed to inhibit I Ca . Upon removal of M-2, CCh (100 M) caused an inhibition of I Ca . Figure 6 , B and C, summarizes the CCh-induced suppression of I Ca in the presence of M-2 (1 and 3 M) when the peak amplitude of I Ca was normalized as one just before application of several drugs (i.e., control).
Effect of M-2 on Smooth Muscle Cells in Intact Urinary Bladder. Evoked Ca 2ϩ transients in urinary bladder smooth muscle cells were characterized as present when the fluorescent signal rose rapidly within 0.5 s of the field stimulus (while stimulating at 0.33 Hz) to stimulate nerves in the absence (i.e., control) (Supplemental Movie A) and presence (Supplemental Movie B) of M-2. As shown in Fig. 7A , such evoked Ca 2ϩ transients fell into two groups. First, a "fast" group was defined on the basis of a very fast rising phase and characterized by a Ca 2ϩ response over the whole cell. Second, a "slow" group was defined on the basis of a slower rising phase and characterized by the presence of Ca 2ϩ waves. Under control conditions (DMSO or saline only), most field stimuli induced an increase in fluorescence within the smooth muscle cells (fast, P ϭ 0.82 Ϯ 0.06; slow, P ϭ 0.09 Ϯ 0.04; total, P ϭ 0.91 Ϯ 0.02; Fig. 7B ). In response to a cumulative concentration-response protocol (n ϭ 4 urinary bladders; 12 cells), more than half of the fast Ca 2ϩ transients were abolished at 30 nM M-2, and only slow transients remained. These slow Ca 2ϩ transients were present until concentrations exceeded 1 M. Upon exposure of the intact mice urinary bladder to ACh (100 M), Ca 2ϩ waves could be induced in Fig. 8A . These wave occurrences were often periodic rather than random (Fig. 8B) . After washing out the ACh and 
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leaving the preparation for 25 min, a repeat application of ACh could again generate Ca 2ϩ waves with a similar frequency ( Fig. 8C ; n ϭ 9 cells from three urinary bladders). M-2 (3 M) was then added and had no significant effect on the wave frequency at rest. However, when ACh was applied in the presence of M-2 (3 M), ACh no longer induced Ca 2ϩ waves (Fig. 8 ).
Discussion
We have been able to demonstrate the following. M-1 but not M-2 inhibited I Ca in dispersed myocytes from murine detrusor; M-2 antagonized the CCh-induced suppression of I Ca through muscarinic type 3 receptors; and M-2 suppressed ACh-induced Ca 2ϩ transients in intact murine urinary bladder.
Effects of Propiverine and Two of Its Main Metabolites (M-1 and M-2) on I Ca . It is well known that propiverine suppresses I Ca in dispersed detrusor myocytes: rat (K i ϭ 7 M) (Tokuno et al., 1993) , guinea pig (K i ϭ 21 M) (Tokuno et al., 1993) , and human (K i ϭ 4 M) (Wuest et al., 2007) . Our data confirmed the inhibitory effects of propiverine on I Ca (i.e., L-type Ca 2ϩ currents) in murine detrusor myocytes with a similar potency (murine, K i ϭ 10 M). In recent studies, it has been reported that propiverine and M-1, but not M-2, have significant binding affinity to L-type Ca 2ϩ channels (competing with a known antagonist) in rat urinary bladder (propiverine, (Uchida et al., 2007) , similar to the inhibitory potency in the present experiments (murine detrusor myocytes; propiverine,
In recent studies, it has been reported that M-1 and M-2, which Wuest et al. (2005) abbreviate as M-5 and M-6, respectively, have little inhibitory effect on I Ca in human detrusor myocytes, with M-2 slightly inhibiting the peak current with an EC 50 of just over 10 M and no significant effect of M-1 up to 100 M (Wuest et al., 2007) . In the present experiments, M-1, but not M-2, inhibited the peak amplitude of I Ca in a concentration-and voltage-dependent manner. We are not certain whether these differences between the present work and that of Wuest et al. (2005) are due to different experimental conditions (such as different charge carriers for Ca 2ϩ channels, i.e., Ca 2ϩ versus Ba 2ϩ ) or species differences (humans compared with mice).
When the holding potential was elevated from Ϫ90 to Ϫ60 
124
mV, the concentration response curve for M-1 was shifted to the left. The voltage-dependent inactivation curve was also significantly shifted to the left after application of 100 M M-1, without altering the activation kinetics of I Ca . These results strongly suggest that the voltage-dependent inhibitory actions of M-1 occur at the inactivated state of the L-type Ca 2ϩ channels in murine urinary bladder smooth muscle cells (i.e., voltage-dependent block). Upon removal of M-1, the peak amplitude of I Ca did not recover to the control level. We suggest that M-1 may tightly bind L-type Ca 2ϩ channels, producing a long-lasting effect on L-type Ca 2ϩ channels. However, the high concentrations of M-1 at which this occurs are unlikely to be reached during in vivo administration of propiverine (in which M-1 reaches a peak of approximately 2 M) (Siepmann et al., 1998) .
Cholinergic Suppression of I Ca through Muscarinic Type 3 Receptor. Application of CCh gradually inhibited the peak amplitude of I Ca . After washout of CCh, the peak amplitude of I Ca slowly recovered. These results suggest that CCh inhibits I Ca through indirect pathways, such as G-protein-coupled regulatory mechanisms.
In the present experiments, CCh caused a concentrationdependent inhibition of the peak amplitude of I Ca in murine detrusor myocytes when EGTA (5 mM) was included in the pipette solution. Furthermore, there was no suppression induced by CCh when GDP␤S was present in the pipette solution. A similar observation was obtained in human and pig detrusor myocytes (Kajioka et al., 2002) . Thus, we suggest that intracellular Ca 2ϩ -insensitive and G-protein-coupled mechanisms seem to be involved in the inhibitory mechanisms. Although both muscarinic type 2 and muscarinic type 3 receptors are expressed in the urinary bladder [specific immunoprecipitation (Wang et al., 1995) and mRNA transcripts (Yamaguchi et al., 1996) ], it is generally believed that the muscarinic type 3 receptor is dominant in the urinary bladder from several species (Wang et al., 1995) . Of the three subtype-specific antagonists for muscarinic receptors, only 4-DAMP, the muscarinic type 3 receptor antagonist, potently prevented the CCh-induced inhibition of I Ca in murine detrusor myocytes. Moreover, immunohistochemical studies also indicated the presence of muscarinic type 3 receptor proteins in detrusor smooth muscle bundles. Taken together, these results indicate that G-protein activation via muscarinic stimulation, probably through muscarinic type 3 receptors, inhibits I Ca in murine detrusor myocytes.
Thus, muscarinic type 3 receptor activation in the intact preparation has two opposing effects on Ca 2ϩ influx. First, it causes depolarization, probably activating SKF-96365-sensitive receptor-operated cation channels (Kajioka et al., 2005) . The depolarization opens voltage-gated Ca 2ϩ channels. Second, activating muscarinic type 3 receptors changes voltagegated Ca 2ϩ channel kinetics as described in the present work; this action reduces or limits the Ca 2ϩ current activated by depolarization.
In recent studies, using binding techniques, it has been reported that propiverine and its main metabolites (M-1 and M-2) bind to all five subtypes of human muscarinic receptors (i.e., muscarinic type 1-5 receptors) that were expressed in Chinese hamster ovary cells and that the order of affinity for all subtypes of muscarinic receptors is mostly M-2 Ͼ propiverine Ͼ M-1 (Maruyama et al., 2006; Wuest et al., 2006) . In the present experiments, pretreatment with 3 M M-2 completely antagonized the CCh-induced suppression of I Ca in murine detrusor myocytes. These results suggest that M-2 may functionally antagonize muscarinic type 3 receptors.
M-2 Modulates Ca 2؉ Transients in Intact Urinary Bladder Smooth Muscle. In recent studies, it has been reported that propiverine and M-2 suppressed CCh (1 M)-induced [Ca 2ϩ ] i elevation in human embryonic kidney-293 cells stably transfected with human muscarinic type 3 receptors, with very similar potency (M-2, IC 50 ϭ 5 M; propiverine, IC 50 ϭ 3 M) (Wuest et al., 2006) . Thus, they concluded that the antimuscarinic actions of propiverine in vivo are mainly due to the actions of M-2 (Wuest et al., 2006) .
We have demonstrated two distinct types of Ca 2ϩ transients evoked by electrical stimulus in murine urinary smooth muscle cells, namely a fast type and a slow type. In controls, the fast Ca 2ϩ transients were dominant when field stimuli were applied. These were similar to the nifedipinesensitive whole cell Ca 2ϩ elevations present in guinea pig urinary bladder that are associated with spontaneous action potentials (Hashitani et al., 2001) . When 30 nM M-2 was applied, more than half of the fast Ca 2ϩ transients evoked by electrical stimulation were abolished. The slow Ca 2ϩ transients were suppressed at 1 M M-2, showing a different potency of M-2 between the two types of Ca 2ϩ transients. The cellular mechanisms generating fast or slow Ca 2ϩ transients after field stimulation were not further characterized. However, it has recently been reported that there are two types of nifedipine-sensitive spontaneous action potentials in the mouse urinary bladder, with median half-rise times that differ by approximately 45 ms (8 ms compared with 53 ms); CCh increased the frequency of both types of action potential (Meng et al., 2007) . If these two types of action potentials also arise after field stimulation, perhaps they could be associated with the fast and slow Ca 2ϩ transients reported in the present study. Meng et al. (2007) noted that spontaneous Ca 2ϩ transients occurred with a frequency similar to that of spontaneous action potentials, although the recording rate used (5 Hz) would not have been sufficient to distinguish between differences in Ca 2ϩ rise times that matched the rise times of the two types of action potentials (Meng et al., 2007) .
The present results suggest that M-2 suppressed Ca 2ϩ transients in intact urinary bladder smooth muscle with higher potency (lower IC 50 value) than it did for overexpressed muscarinic type 3 receptors in human embryonic kidney-293 cells. We detected Ca 2ϩ transients evoked by electrical stimulus in intact smooth muscle cells, and the Ca 2ϩ transients are related to the physiological release of neurotransmitter (ACh and ATP). Moreover, ACh-induced Ca 2ϩ transients in intact urinary bladder were almost abolished by pretreatment with M-2 (3 M), demonstrating that M-2 might also act downstream of the muscarinic receptor to inhibit the Ca 2ϩ transients. We cannot rule out an additional effect on purinergic transmission. Thus, the present work supports the view that the propiverine metabolite M-2 functionally modified urinary bladder contraction predominantly through muscarinic receptors. Given the effectiveness of M-2 (at 1 M) in inhibiting CCh-induced and field stimulationinduced contraction (Wuest et al., 2005) and its lack of action on Ca 2ϩ channels, M-2 might prove to be more clinically useful than propiverine.
In conclusion, high concentrations of M-1 but not M-2 inhibited the peak amplitude of I Ca in dispersed smooth muscle cells of murine urinary bladder. M-2 antagonized the CCh-induced suppression of I Ca through muscarinic type 3 receptors. M-2 also suppressed electric field stimulation-induced and ACh-induced Ca 2ϩ transients in intact murine urinary bladder.
